Federated Hermes’s Vor Biopharma VOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$14.5M Buy
+760,221
New +$16.2M 0.02% 572
2025
Q2
– Sell
-99
Closed -$1.42K – 2200
2025
Q1
$1.42K Sell
99
-53
-35% -$1.27K ﹤0.01% 1978
2024
Q4
$3.38K Sell
152
-36
-19% -$597 ﹤0.01% 1930
2024
Q3
$2.63K Buy
188
+8
+4% +$146 ﹤0.01% 1925
2024
Q2
$3.6K Buy
+180
New +$5.82K ﹤0.01% 1867
2022
Q2
– Sell
-4
Closed -$1K – 2289
2022
Q1
$1K Buy
+4
New +$681 ﹤0.01% 2123

Other funds holding VOR

Federated Hermes's VOR Position: Q3 2026 in Review

Federated Hermes opened a new position in Vor Biopharma (VOR) in Q3 2026: 760,221 shares worth $14.5M. The stake represents 0.02% of the portfolio and ranks #572 among its holdings. This is a return to the name: Federated Hermes previously reported a position in VOR as recently as Q1 2025.

Federated Hermes first reported a position in VOR in Q1 2022 and has held it in 6 quarters since. 76 funds tracked by Wall St. Rank hold VOR as of Q3 2026.

  • Federated Hermes held 760,221 shares of Vor Biopharma worth $14.5M as of Q3 2026.
  • Vor Biopharma was a new Federated Hermes position in Q3 2026.
  • Vor Biopharma made up 0.02% of Federated Hermes's portfolio in Q3 2026, its #572 holding.
  • Federated Hermes first reported a position in Vor Biopharma in Q1 2022 and has held it in 6 quarters since.
  • 76 funds tracked by Wall St. Rank held Vor Biopharma as of Q3 2026.

Based on Federated Hermes's 13F filing for Q3 2026, filed 12 Nov 2026.